Ticks are blood-feeding external parasites of mammals.
Almost all ticks belong to one of two major families, the Ixodidae or hard ticks, and the Argasidae or soft ticks.
Ticks are responsible of transmitting many diseases called 'tick-borne diseases'. Borrelia and Rickettsia spp., are the most important tick-transmitted bacterial pathogens circulating in Europe. In this review we will focus on the two tick-borne diseases caused by these bacterial pathogens, their vector, epidemiology, clinical diagnosis and symptoms.
Ticks are blood-feeding external parasites of mammals, birds and reptiles throughout the world. They belong to the order Ixodida.
Almost all ticks belong to one of two major families, the Ixodidae or hard ticks, which are difficult to crush, and the Argasidae or soft ticks. The Ixodidae contain over 700 species of hard ticks with a scutum or hard shield, which is missing in the Argasidae family.
The Argasidae contain about 200 species 1 ; Table 1 shows the most important tick-borne diseases and their vectors.
Tick-borne diseases have been described throughout human history. A papyrus scroll dating back to the 16th century B.C. referred to what could be 'tick fever' 2 . At the end of the nineteenth century, Theobald Smith and Frederick Kilbourne were the first to demonstrate that ticks were responsible for transmitting diseases. Their experiment in cattle allowed them to conclude that the absence of ticks lead to the absence of Texas fever 3 . In this review we will focus on Borrelia and Rickettsia spp., the most important tick-transmitted bacterial pathogens circulating in Europe.
several bird species 7 . Birds are more likely to carry B. garinii, so this microorganism may be carried over very long distances, especially in the case of migratory sea birds 8 .
Epidemiology
LB is one of the most prevalent vector-borne diseases in Europe
9
.
However, precise epidemiological data are not available for all
European countries because the disease is notifiable in only a few countries 10, 11 . The highest average incidence rates among the reporting countries were found in Belarus, Belgium, Croatia, Norway, the Russian Federation and Serbia (<5/100 000), Bulgaria, Finland, Hungary, Poland and Slovakia (<16/100 000), the Czech Republic, Estonia, and Lithuania (<36/100 000) and Slovenia (<130/100 000) (ecdc.europa.eu).
There are clear differences in LB incidence rates and clinical presentations across Europe
12
. Incidence rates in European countries vary from less than less than one per 100 000 inhabitants to about 350 per 100 000, with a mean annual number of notified cases in Europe exceeding 65 400 13 . Furthermore, the incidence rates of LB across Europe are influenced by geographical, environmental and climatic factors 14, 15 . Studies on the future potential distribution of I. ricinus notably showed that this tick may emerge in European areas in which they are currently lacking, thus leading to an increased risk to human health 16 .
Clinical symptoms and diagnosis
During LB, symptoms may vary depending on the stage of the disease. Early LB may be divided into early localised (1-4 weeks after the tick-bite) and early disseminated (3-10 weeks after the tick-bite) diseases, while late disseminated LB develops months to years later. In early LB, various clinical manifestations may be identified, notably the pathognomonic erythema migrans.
Erythema migrans (EM) is the most specific and frequent finding in patients with LB. European studies showed that it is present in 40 to 77% of LB patients 17 . Primary erythema migrans is a round or oval, expanding erythematous skin lesion that develops at the site of the infecting tick-bite 18 . Three to 30 days after the tick bite the skin lesion becomes apparent (most commonly 7-14 days).
It is not associated with significant pruritis 19 . If the skin lesion disappears within a few days, it is not considered as an EM. Other Under the Microscope secondary ring-shaped lesions may develop in certain cases and are named multiple EM. Less common LB symptoms are cited in Table 2 .
The diagnosis of LB is difficult due to the unspecific nature of the majority of clinical symptoms, and makes laboratory support crucial. The culture of Borrelia spp. is time consuming and labor intensive, and is thus not used for the routine diagnosis 20 . In addition, in Europe, the microbiological diagnosis of LB must consider the heterogeneity of the agents depending on countries.
Serology is usually the routine method used to support clinical diagnosis 19, 20 . However, serology suffers limitations. In particular, the antibody response in early LB may be weak or absent, especially in EM and early LNB 21 . Western blotting is used currently as a confirmatory assay in the serodiagnosis of LB, but is usually only employed following a positive screening assay. In addition, many biomolecular tests were developed in order to supplement western blot such as sensitive and specific Lyme Multiplex PCR-dot blot assay (LM-PCR assay) and nested polymerase chain reaction (nPCR) 21 applicable to blood and urine samples. However, PCRbased methods are not standardised.
Rickettsioses

Causative agents and vectors
Rickettsioses are worldwide zoonosis caused by obligate intracellular bacteria from the genera Rickettsia and Orientia. These bacteria belong to the alpha-Proteobacteria (Figure 1 
Epidemiology
The prevalence of tick-borne rickettsioses depends on several parameters and most of them are directly related to the tick vectors: (i) the abundance of the tick itself, which is influenced by many factors, including climatic and ecological conditions;
(ii) their affinity for humans; and (iii) the prevalence of Figure 1 ).
Clinical symptoms and diagnosis
Typically, the clinical symptoms of tick-borne rickettsioses develop 6 to10 days after a tick-bite. Human rickettsioses are characterised by various combinations of symptoms, the most common being a triad consisting of a generalised maculopapular rash, an eschar at the inoculation site ( Figure 2 ) and flu-like symptoms including high grade fever, myalgia, malaise, headache and nausea 25 .
However, depending on species and the underlying patient's status, these major clinical signs vary greatly.
The diagnosis of rickettsial infections usually relies on epidemioclinical data, and may be confirmed by laboratory testing 6 . In addition, the arthropods collected at the bite site or eschar may be useful for the diagnosis.
Serology is the most commonly used and available method worldwide due to its quick turnaround time, need for minimal sample preparation and to the serological cross-reactions observed among Rickettsia species that enable limiting the number of tested antigens 6 . Molecular testing is also well adapted for the diagnosis of tick-borne rickettsioses 26 . 
Conclusion
In Europe, the number of vector-borne disease is increasing in 
